Balloon catheter coated with an active ingredient and an anti-restenotic agent molecular dispersion promotes the transport

Catheter balloon with or without stent tablet, wherein the surface of the catheter balloon is at least partially covered by at least one anti-restenotic agent and at least one molecular promoter transport dispersant, wherein at least one molecular promoter transport dispersant is to least one compound of general formula l (I): where X1 ** ** formula represents one of the following residues: -L1-R18, -C (R3) (R4) -L1-R18, -L1-C (R3) (R4) -R18, -C (R3) (R4) L 1 C (R5) (R6) -R18, -L1-Y-R18, -Y-L1-R18, -YC (R3) (R4) - L1-R18, -C (R3) (R4) -Y-L1-R18, -C (R3) (R4) -L1-Y-R18, -Y-L1-C (R3) (R4) -R18, - L1-YC (R3) (R4) -R18, -L1-C (R3) (R4) -Y-R18, -YC (R3) (R4) -L1-C (R5) (R6) -R18, -C (R3) (R4) -Y-L1-C (R5) (R6) -R18, -C (R3) (R4) -L1-Y- C (R5) (R6) -R18, -C (R3) ( R4) -L1-C (R5) (R6) -Y-R18; X2 represents one of the following radicals -R 7, (-CH2-) p-R7, (-O-CH2-) p-R7; X3 represents one of the following residues -M1-R26, -M1-M2-R26, M1 (M2) r-M3-R26, M1 (M2) r-M3- (M4) s-R26; X4 represents one of the following residues -L2-R19, -C (R10) (R11) -L2-R19, -L2-C (R10) (R11) -R19, -C (R10) (R11) -C (R12 ) (R13) -L2-R19, -C (R10) (R11) L2 C (R12) (R13) -R19, -L2-C (R10) (R11) -C (R12) (R13) -R19 ; L1 represents one of the following groups ** ** Formula